Pulse Biosciences (PLSE) Non-Current Assets (2015 - 2026)

Pulse Biosciences has reported Non-Current Assets for 12 years, with the latest figure at $9.9 million in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 18.42% year-over-year to $9.9 million in Q2 2026; TTM through Jun 2026 was $44.7 million, a 11.01% decrease from a year earlier, with the FY2025 full-year figure at $11.1 million, down 14.55% from the prior year.
• Non-Current Assets was $9.9 million for Q2 2026 at Pulse Biosciences, down from $11.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $17.4 million in Q1 2022, with the low at $9.9 million in Q2 2026.
• Average Non-Current Assets over 5 years is $13.8 million, with a median of $13.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Non-Current Assets climbed 13.77% in 2022, then dropped 18.42% in 2026.
• Over 5 years, Non-Current Assets stood at $15.7 million in 2022, then retreated by 12.1% to $13.8 million in 2023, then retreated by 5.89% to $13.0 million in 2024, then retreated by 14.55% to $11.1 million in 2025, then dropped by 11.28% to $9.9 million in 2026.
• The last three Non-Current Assets figures came in at $9.9 million (Q2 2026), $11.1 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.